History of coronary heart disease increased the mortality rate of patients with COVID-19: a nested case–control study
Objective Evaluate the risk of pre-existing comorbidities on COVID-19 mortality, and provide clinical suggestions accordingly.Setting A nested case–control design using confirmed case reports released from the news or the national/provincial/municipal health commissions of China between 18 December...
Saved in:
Main Authors: | Yaping He, Lei Xu, Tian Gu, Qiao Chu, Zhangsheng Yu, Botao Fa, Anqi Li, Ruijun Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-09-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/9/e038976.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Digoxin Use to Control Ventricular Rate in Patients with Atrial Fibrillation and Heart Failure Is Not Associated with Increased Mortality
by: Surbhi Chamaria, et al.
Published: (2015-01-01) -
Assessment of heart rate deceleration capacity, heart rate deceleration runs, heart rate acceleration capacity, and lipoprotein-related phospholipase A2 as predictors in individuals with dementia
by: Yaping Wang, et al.
Published: (2025-01-01) -
Predictive effect of estimated glomerular filtrate rate by creatinine or cystatin C on mortality in patients with coronary artery disease
by: Shiqun Chen, et al.
Published: (2024-12-01) -
Model for End-Stage Liver Disease Score Predicts the Mortality of Patients with Coronary Heart Disease Who Underwent Percutaneous Coronary Intervention
by: You Chen, et al.
Published: (2021-01-01) -
Association of Time in Target Range of Resting Heart Rate With Adverse Clinical Outcomes in Patients With Acute Coronary Syndromes After Percutaneous Coronary Intervention
by: Jianmei Zheng, et al.
Published: (2025-01-01)